We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combined Approach Cures Bladder Cancer in Model

By LabMedica International staff writers
Posted on 28 Aug 2017
Print article
Image: A scanning electron micrograph (SEM) of a gold nanostar. The nanostar\'s size caused it to accumulate within tumors, where researchers used infrared light to heat it and destroy cancerous growths (Photo courtesy of Dr. Tuan Vo-Dinh, Duke University).
Image: A scanning electron micrograph (SEM) of a gold nanostar. The nanostar\'s size caused it to accumulate within tumors, where researchers used infrared light to heat it and destroy cancerous growths (Photo courtesy of Dr. Tuan Vo-Dinh, Duke University).
A novel anticancer "photothermal immunotherapy" technique that used lasers and gold nanostars to heat up and destroy tumors in combination with an immunotherapeutic drug cured and immunized mice against bladder cancer in a small proof-of-concept study.

Investigators at Duke University (Durham, NC, USA) had previously described the development of plasmonic gold nanostar particles, which had multiple sharp spikes that were able to capture laser energy more efficiently. In the current study, gold nanostar therapy was combined with an immunotherapeutic drug that inhibited the activity of PD-L1 (Programmed death-ligand 1), which would otherwise disable cancer-destroying T-cells.

In the current proof-of-concept study, MB49 bladder cancer cells were injected into the hind legs of a group of mice. After tumors began to grow, the animals were treated in one leg only with gold nanostars and laser heating, nanostars plus PD-L1 inhibitor, or PD-L1 inhibitor alone. A group of control animals were not treated.

Results published in the August 17, 2017, online edition of the journal Scientific Reports revealed that animals receiving no treatment rapidly died from cancer, as did those receiving only the gold nanostar phototherapy, since the treatment did nothing to affect the tumor growing in the untreated leg. In contrast, some animals responded well to the immunotherapy alone, with the drug slowing growth of both tumors, but none survived more than 49 days. However, animals in the group treated with both the immunotherapy and the gold nanostar phototherapy fared much better, with two of the five mice surviving more than 55 days.

The investigators referred to the two-pronged treatment approach as Synergistic Immuno Photothermal Nanotherapy (SYMPHONY). Using this combination of immune-checkpoint inhibition and plasmonic gold nanostar–mediated photothermal therapy, they were able to achieve complete eradication of primary treated tumors and distant untreated tumors in some mice implanted with the MB49 bladder cancer cells. Delayed rechallenge of mice cured by SYMPHONY with injections of MB49 cancer cells did not lead to new tumor formation after 60 days observation, indicating that SYMPHONY treatment induced effective long-lasting immunity against MB49 cancer cells.

"The nanostar spikes work like lightning rods, concentrating the electromagnetic energy at their tips," said senior author Dr. Tuan Vo-Dinh, professor of chemistry and biomedical engineering at Duke University. "We have experimented with these gold nanostars to treat tumors before, but we wanted to know if we could also treat tumors we did not even know were there or tumors that have spread throughout the body. When a tumor dies, it releases particles that trigger the immune system to attack the remnants. By destroying the primary tumor, we activated the immune system against the remaining cancerous cells, and the immunotherapy prevented them from hiding."

"The ideal cancer treatment is non-invasive, safe, and uses multiple approaches," said Dr. Vo-Dinh. "We also aim at activating the patient's own immune system to eradicate residual metastatic tumors. If we can create a long-term anticancer immunity, then we would truly have a cure."

Related Links:
Duke University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.